Bellerophon Therapeutics is a clinical-stage biotherapeutics company. We are focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. More … Continued
Location: United States, New Jersey
Investors 2
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| 17.07.2021 | ARCH Ventu... | archventur... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 02.04.2020 | ARCH Ventu... | ARCH said it would use its two... | - | - | medcitynew... |
| 13.02.2015 | Belleropho... | Bellerophon Therapeutics (NSDQ... | - | Brad Perri... | massdevice... |
| - | ARCH Ventu... | Two large venture capital firm... | - | - | medcitynew... |